USNA (Usana Health Sciences) Beginning Cash Position : $335.2 Mil (As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Usana Health Sciences Beginning Cash Position?

Usana Health Sciences's Beginning Cash Position for the quarter that ended in Sep. 2024 was $335.2 Mil.

Usana Health Sciences's quarterly Beginning Cash Position declined from Mar. 2024 ($333.2 Mil) to Jun. 2024 ($331.1 Mil) but then increased from Jun. 2024 ($331.1 Mil) to Sep. 2024 ($335.2 Mil).

Usana Health Sciences's annual Beginning Cash Position declined from Dec. 2021 ($315.9 Mil) to Dec. 2022 ($243.7 Mil) but then increased from Dec. 2022 ($243.7 Mil) to Dec. 2023 ($291.3 Mil).

Usana Health Sciences Beginning Cash Position Historical Data

The historical data trend for Usana Health Sciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences Beginning Cash Position Chart

Usana Health Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

217.23

237.69

315.94

243.65

291.32

Usana Health Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beginning Cash Position	Get a 7-Day Free Trial															302.94	309.82	333.25	331.11	335.18

Usana Health Sciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Usana Health Sciences Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Usana Health Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (NYSE:USNA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

USJ:Germany USJ:Germany

Address

3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120

Website

http://www.usanahealthsciences.com

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Executives

Gilbert A Fuller	officer: CFO and Executive V.P.	55 WANDERWOOD WAY, SANDY UT 84092
Paul A. Jones	officer: CFO	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
John Turman Fleming	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Myron W Wentz	director	3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
G Doug Iiekking	officer: VP of Finance	C/O USANA HEALTH SCIENCES INC, 3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
Daniel A. Macuga	officer: Chief Communications Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Kevin Guest	officer: E.V.P. of Marketing	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Walter Noot	officer: Chief Information Officer	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Brent Neidig	officer: CO & Man. Dir. of China	3838 WEST PARKWAY BLVD., WEST VALLEY CITY UT 84120
Robert A Sinnott	officer: Chief Scientific Officer	400 55 WATER STREET, VANCOUVER A1 V6B1A1
David Mulham Mulham	officer: Chief Field Development Office	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Joshua Foukas	officer: Chief Legal Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY X1 84120
Peggie Pelosi	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84111
Frederic J Winssinger	director	2944 N 44TH STREET, SUITE 250, PHOENIX AZ 85018
Xia Ding	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120